| Study Details | To Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment |
| Protocol Number | D7000C00001 |
| Phase | I/III |
| Therapeutic Area | Infectious Diseases |
| Subject Types | With Medical Condition |
| Indication | Pre-exposure Prophylaxis of COVID-19 with Immune Impairment |
| Principal Investigator | A/Prof Louis Yi Ann Chai |
| Investigator Product / Device | AZD5156/AZD3152 |
| Sponsor | AstraZeneca AB |
